Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

3

Revenue 2014

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt

Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt

It is the second IL-6 inhibitor to reach the US market after Roche's Actemra (tocilizumab), which made its debut in 2010 and is a big earner for the Swiss ... Kevzara has a dosing advantage over Roche's drug, which is given either by intravenous

Merck says Afferent’s chronic cough drug clears mid-stage trial

Merck says Afferent’s chronic cough drug clears mid-stage trial years. Two drugs have been approved for IPF - Roche's Esbriet (pirfenidone) and Boehringer Ingelheim's Ofev (nintedanib) - but while they can delay disease progression neither has a significant impact on

Novartis' Zykadia prepped to take on Xalkori in Europe

Novartis' Zykadia prepped to take on Xalkori in Europe Zykadia could see tough competition in NSCLC from Roche's Alecensa (alectinib), which bested Xalkori in the head-to-head ALEX trial reported last month adding to growing momentum for

Payback time nears as Sanofi gets CHMP backing for biosimilar Humalog

Payback time nears as Sanofi gets CHMP backing for biosimilar Humalog The CHMP also backed three biosimilars of Roche's Rituxan (rituximab) developed by Celltrion namely Blitzima, Tuxella and Ritemvia.

Merck takes on Roche with first-line bladder OK for Keytruda

Merck takes on Roche with first-line bladder OK for Keytruda Merck takes on Roche with first-line bladder OK for Keytruda. FDA awards accelerated approval for mUC patients. ... Keytruda joins Roche's Tecentriq (atezolizumab) in the first-line UC treatment setting, and Tecentriq and three other checkpoint

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Roche
Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA
US revenue 2014
1: Gilead Sciences
2: Johnson & Johnson
3: Pfizer
4: Roche
5: Novartis
6: Amgen
7: Merck & Co.
8: Sanofi
9: AbbVie
10: Actavis
11: AstraZeneca
12: GlaxoSmithKline
13: Lilly
14: Bristol-Myers Squibb
15: Novo Nordisk
Oncology revenue 2014
1: Roche
2: Novartis
3: Celgene
4: Johnson & Johnson
5: Bristol-Myers Squibb
6: Lilly
7: Takeda
8: AstraZeneca
9: Merck & Co.
10: Amgen
11: Pfizer
12: Astellas
13: Bayer
14: Otsuka
15: Sanofi
16: Merck KGaA
17: Eisai
18: AbbVie
19: Pharmacyclics
20: Incyte
Immunology revenue 2014
1: AbbVie
2: Johnson & Johnson
3: Pfizer
4: Amgen
5: Merck & Co.
6: Astellas
7: Roche
8: Novartis
9: Bristol-Myers Squibb
10: Mitsubishi Tanabe
11: UCB
12: Hisamitsu
13: Daiichi Sankyo
14: Takeda
Cardiovascular revenue 2014
1: AstraZeneca
2: Sanofi
3: Merck & Co.
4: Daiichi Sankyo
5: Pfizer
6: Novartis
7: Bayer
8: Takeda
9: Boehringer Ingelheim
10: Astellas
11: Actelion
12: Johnson & Johnson
13: Shionogi
14: United Therapeutics
15: Bristol-Myers Squibb
16: Gilead Sciences
17: Otsuka
18: Roche
19: Lilly
20: The Medicines Company
Biologic revenue 2014
1: Roche
2: Amgen
3: Novo Nordisk
4: AbbVie
5: Sanofi
6: Johnson & Johnson
7: Pfizer
8: Merck & Co.
9: Lilly
10: Biogen Idec
11: Merck KGaA
12: GlaxoSmithKline
13: Bristol-Myers Squibb
14: Novartis
15: Bayer

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Issue 3: SPOTLIGHT ON… Content Marketing
For the 3rd edition we’re focussing on one of our favourite topics, and one we are really passionate about – content marketing....
Executional Excellence - creating work that works
What drives us at BLH is the opportunity to make a real difference – and for our clients, that difference is measured both in customer outcomes and commercial outcomes. In...
Untitled-design.jpg
What's next after e-detailing?
You have your e-detailing system in place and are now thinking about multichannel. You want to provide a seamless customer experience across all channels – websites, apps, social media platforms,...

Infographics